News Focus
News Focus
icon url

DewDiligence

10/24/12 8:34 AM

#151143 RE: dav1234 #151134

BMY’s Reyataz sales fell 7% YoY, the first such decline in a long time. GILD’s Stribild could already be taking significant share from PI-based regimens.